Shares of KindlyMD, Inc. (NASDAQ:NAKA – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $6.6240, but opened at $5.96. KindlyMD shares last traded at $6.65, with a volume of 99,640 shares trading hands.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on NAKA. B. Riley Financial lowered their price objective on KindlyMD from $1.00 to $0.50 and set a “buy” rating on the stock in a research report on Monday, February 23rd. Maxim Group lowered their price objective on KindlyMD from $1.50 to $0.75 and set a “buy” rating on the stock in a research report on Monday, April 6th. TD Cowen initiated coverage on KindlyMD in a report on Friday, April 10th. They issued a “buy” rating and a $1.00 price target on the stock. Finally, Weiss Ratings raised KindlyMD from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. Three investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $0.75.
Get Our Latest Analysis on KindlyMD
KindlyMD Stock Performance
Institutional Trading of KindlyMD
A number of large investors have recently added to or reduced their stakes in the company. J. Derek Lewis & Associates Inc. bought a new position in shares of KindlyMD during the 4th quarter valued at approximately $167,000. Virtu Financial LLC purchased a new stake in KindlyMD during the 4th quarter valued at $151,000. Invesco Ltd. purchased a new stake in KindlyMD during the 4th quarter valued at $211,000. NewEdge Advisors LLC purchased a new stake in KindlyMD in the fourth quarter worth $316,000. Finally, Saba Capital Management L.P. bought a new stake in KindlyMD during the 4th quarter valued at about $1,399,000.
KindlyMD Company Profile
Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.
Featured Stories
- Five stocks we like better than KindlyMD
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.
